CENTURY THERAPEUTICS INC. - COMMON STOCK

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

15 Apr 2025 16:01:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

19 Mar 2025 16:01:00 By Nasdaq GlobeNewswire

Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders

21 Jan 2025 07:00:19 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

26 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

05 Nov 2024 09:05:00 By Nasdaq GlobeNewswire

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting

05 Nov 2024 09:00:01 By Nasdaq GlobeNewswire

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference

04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

26 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

08 Aug 2024 07:30:00 By Nasdaq GlobeNewswire

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

03 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting

10 May 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

09 May 2024 07:30:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

23 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

11 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

08 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

19 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

14 Mar 2024 07:30:00 By Nasdaq GlobeNewswire

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

05 Mar 2024 18:03:06 By Nasdaq GlobeNewswire

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

09 Dec 2023 12:00:00 By Nasdaq GlobeNewswire